Product Description: KDM2B-IN-2, a potent histone demethylase (kdm2b) inhibitor with an IC50 of 0.021 μM in a KDM2B TR-FRET assay. KDM2B-IN-2 can be used for hyperproliferative diseases research[1].
Applications: COVID-19-immunoregulation
Formula: C21H26N4O2S2
References: [1]Brian K. Albrecht, et al. 4,5-dihydroimidazole derivatives and their use as histone demethylase (kdm2b) inhibitors. Patent WO2016112251A1.
CAS Number: 1965248-01-4
Molecular Weight: 430.59
Compound Purity: 99.36
Research Area: Cancer; Inflammation/Immunology
Solubility: DMSO : 31.25 mg/mL (ultrasonic;heat to 80°C)